FMP
Global Cord Blood Corporation
CO
NYSE
Inactive Equity
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.
2.99 USD
0 (0%)
Operating Data
Year
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Revenue
6.47B
5.09B
6.01B
5.93B
5.27B
5.07B
4.87B
4.68B
4.5B
4.32B
Revenue %
-
-21.28
18.09
-1.39
-11.04
-3.91
-3.91
-3.91
-3.91
Ebitda
-292.1M
-214.6M
-291.3M
-240.4M
24.5M
-174.01M
-167.22M
-160.69M
-154.41M
-148.38M
Ebitda %
-4.52
-4.22
-4.85
-4.06
0.46
-3.43
-3.43
-3.43
-3.43
Ebit
-388.3M
-295.4M
-368.5M
-302.1M
-31.7M
-239.54M
-230.19M
-221.2M
-212.56M
-204.26M
Ebit %
-6.01
-5.8
-6.13
-5.1
-0.6
-4.73
-4.73
-4.73
-4.73
Depreciation
96.2M
80.8M
77.2M
61.7M
56.2M
65.53M
62.97M
60.51M
58.15M
55.88M
Depreciation %
1.49
1.59
1.28
1.04
1.07
1.29
1.29
1.29
1.29
EBIT (Operating profit)(Operating income)(Operating earning) = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT) EBIT = (1*) (2*) -> operating process (leverage -> interest -> EBT -> tax -> net Income) EBITDA = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT) + Depreciation + amortization EBITA = (1*) (2*) (3*) (4*) company's CURRENT operating profitability (i.e., how much profit it makes with its present assets and its operations on the products it produces and sells, as well as providing a proxy for cash flow) -> performance of a company (1*) discounting the effects of interest payments from different forms of financing (by ignoring interest payments), (2*) political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill) (3*) collections of assets (by ignoring depreciation of assets) (4*) different takeover histories (by ignoring amortization often stemming from goodwill)
